The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $3.36 in the prior trading day, AEON Biopharma Inc. (AMEX: AEON) closed at $1.70, down -49.40%. In other words, the price has decreased by -$49.40 from its previous closing price. On the day, 0.91 million shares were traded. AEON stock price reached its highest trading level at $1.75 during the session, while it also had its lowest trading level at $1.38.
Ratios:
Our goal is to gain a better understanding of AEON by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.48 and its Current Ratio is at 0.48.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on August 18, 2023, initiated with a Buy rating and assigned the stock a target price of $18.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 11 ’23 when Strathspey Crown Holdings Grou sold 7,380,394 shares for $10.00 per share. The transaction valued at 73,803,940 led to the insider holds 2,031,773 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AEON now has a Market Capitalization of 65930592 and an Enterprise Value of 59361060.
Stock Price History:
The Beta on a monthly basis for AEON is 0.76, which has changed by -0.6347826 over the last 52 weeks, in comparison to a change of 0.22379243 over the same period for the S&P500. Over the past 52 weeks, AEON has reached a high of $17.17, while it has fallen to a 52-week low of $3.24. The 50-Day Moving Average of the stock is -82.09%, while the 200-Day Moving Average is calculated to be -76.28%.
Shares Statistics:
The stock has traded on average 70.02K shares per day over the past 3-months and 80580 shares per day over the last 10 days, according to various share statistics. A total of 37.16M shares are outstanding, with a floating share count of 11.45M. Insiders hold about 70.48% of the company’s shares, while institutions hold 13.30% stake in the company. Shares short for AEON as of 1713139200 were 432840 with a Short Ratio of 6.18, compared to 1710460800 on 145960.
Earnings Estimates
A comprehensive evaluation of AEON Biopharma Inc. (AEON) is underway, with the input of 1 analysts contributing to its current rating.On average, analysts expect EPS of -$0.31 for the current quarter, with a high estimate of -$0.31 and a low estimate of -$0.31, while EPS last year was $1.15. The consensus estimate for the next quarter is -$0.31, with high estimates of -$0.31 and low estimates of -$0.31.
Analysts are recommending an EPS of between -$1.18 and -$1.18 for the fiscal current year, implying an average EPS of -$1.18. EPS for the following year is -$1.16, with 1.0 analysts recommending between -$1.16 and -$1.16.
